We are live on ! Find out more
RA

RFG Advisory Portfolio holdings

AUM $6.4B
1-Year Est. Return 19.93%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+19.93%
3 Year Est. Return
+52.26%
5 Year Est. Return
+48.57%
10 Year Est. Return
+151.03%
AUM
$5.44B
AUM Growth
+$131M
Cap. Flow
+$221M
Cap. Flow %
4.06%
Top 10 Hldgs %
40.69%
Holding
1,131
New
152
Increased
498
Reduced
363
Closed
94

Sector Composition

Rank Sector Weight
1 Technology 4.5%
2 Consumer Discretionary 1.87%
3 Healthcare 1.72%
4 Financials 1.58%
5 Communication Services 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XCEM icon
651
Columbia EM Core ex-China ETF
XCEM
$1.86B
$686K 0.01%
16,804
-1,228
-7% -$51.5K
VOE icon
652
Vanguard Mid-Cap Value ETF
VOE
$24.1B
$681K 0.01%
3,696
-721
-16% -$135K
RWK icon
653
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.33B
$678K 0.01%
+5,289
New +$698K
SDY icon
654
State Street SPDR S&P Dividend ETF
SDY
$22.3B
$675K 0.01%
4,626
+6
+0.1% +$894
PBE icon
655
Invesco Biotechnology & Genome ETF
PBE
$288M
$674K 0.01%
8,510
+55
+0.7% +$4.45K
PDO
656
PIMCO Dynamic Income Opportunities Fund
PDO
$1.84B
$673K 0.01%
52,073
-1,200
-2% -$16.4K
CCJ icon
657
Cameco
CCJ
$37.9B
$671K 0.01%
+6,174
New +$707K
GEV icon
658
GE Vernova
GEV
$251B
$662K 0.01%
759
+125
+20% +$97.5K
DHR icon
659
Danaher
DHR
$140B
$659K 0.01%
3,477
-1,769
-34% -$377K
CME icon
660
CME Group
CME
$93.5B
$655K 0.01%
2,218
-2,064
-48% -$613K
BUFB icon
661
Innovator Laddered Allocation Buffer ETF
BUFB
$318M
$650K 0.01%
18,100
-1,655
-8% -$60.7K
UYLD icon
662
Angel Oak UltraShort Income ETF
UYLD
$1.57B
$644K 0.01%
12,614
+8,669
+220% +$444K
BX icon
663
Blackstone
BX
$107B
$642K 0.01%
5,583
+1,731
+45% +$225K
MDYG icon
664
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.83B
$636K 0.01%
+6,627
New +$650K
AZN icon
665
AstraZeneca
AZN
$267B
$636K 0.01%
3,224
-4,129
-56% -$796K
FIIG icon
666
First Trust Intermediate Duration Investment Grade Corporate ETF
FIIG
$648M
$634K 0.01%
30,566
+4,711
+18% +$99.2K
GTO icon
667
Invesco Total Return Bond ETF
GTO
$2.42B
$634K 0.01%
13,541
-1,817
-12% -$86.2K
FSLY icon
668
Fastly Inc
FSLY
$3.26B
$630K 0.01%
+21,680
New +$356K
DJUN icon
669
FT Vest US Equity Deep Buffer ETF June
DJUN
$347M
$622K 0.01%
13,222
-623
-4% -$29.6K
IGIB icon
670
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$619K 0.01%
11,624
-25,188
-68% -$1.36M
CGMS icon
671
Capital Group US Multi-Sector Income ETF
CGMS
$5.21B
$618K 0.01%
22,688
-121,684
-84% -$3.36M
MNST icon
672
Monster Beverage
MNST
$95.6B
$616K 0.01%
8,508
+5,416
+175% +$427K
SPLV icon
673
Invesco S&P 500 Low Volatility ETF
SPLV
$7.28B
$605K 0.01%
8,273
+206
+3% +$15.3K
CC icon
674
Chemours
CC
$2.57B
$604K 0.01%
27,405
-28,915
-51% -$503K
OEF icon
675
iShares S&P 100 ETF
OEF
$19.8B
$603K 0.01%
1,896
-10,718
-85% -$3.59M

Similar funds

RFG Advisory's Q1 2026 Portfolio in Review

As of Q1 2026, RFG Advisory held 1,131 positions worth $5.44B, up 2.5% from $5.31B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

RFG Advisory deployed $221M of net new capital in Q1 2026, opening 152 new positions and adding to 498 existing holdings. Its largest new stake was BioCryst Pharmaceuticals: 2,870,700 shares worth $27.3M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 4.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $19.5M trimmed.

  • RFG Advisory's largest Q1 2026 buy was BioCryst Pharmaceuticals: 2,870,700 shares worth $27.3M.
  • RFG Advisory added most to Bluemonte Core Bond ETF in Q1 2026, an estimated $19.8M increase.
  • RFG Advisory's biggest Q1 2026 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $19.5M.
  • RFG Advisory fully exited American Century US Quality Growth ETF in Q1 2026, selling an estimated $8.01M.
  • RFG Advisory's ten largest holdings make up 41% of its $5.44B portfolio in Q1 2026.
  • RFG Advisory opened 152 new positions and closed 94 in Q1 2026.
  • RFG Advisory's portfolio value rose 2.5% quarter-over-quarter to $5.44B.

Based on RFG Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.